Success Stories: Postdoctoral Scholar in the Field of Pharmaceutical Science in New York Receives EB-1A Approval After Only 50 Days

Posted by wegreened on January 30, 2026 in EB1 Green Card, Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine)

Client’s Testimonial:

Thank you very much…Really appreciate your help.

On March 5, 2014, A Postdoctoral Scholar in the Field of Pharmaceutical Science Received EB-1A (Alien of Extraordinary Ability) (Approval Notice) Approval, Only 50 Days After Filing His Case.

General Field: Pharmaceutical Science

Position at the Time of Case Filing: Postdoctoral Research Scholar

Country of Origin: India

State of Residence at the Time of Filing: New York

Approval Notice Date: March 5, 2014

Processing Time: 50 Days

Case Summary:

North America Immigration Law Group – WeGreened.com represented a postdoctoral scholar in the field of Pharmaceutical Science with both an EB-1A (Alien of Extraordinary Ability) petition and an EB-2 NIW petition. This client had contributed towards the development of a spirohydantoin-based method of treating epilepsy, as well as contributing towards the development of a pharmaceutical inhibitor for the treatment of inflammatory diseases. In addition, he had also designed various inhibitors that can contribute towards the treatment of immune disorders and cancer. More recently, this client had researched and designed pharmaceutical inhibitors of glucose regulated protein 94, which is related to disorders such as sepsis and autoimmune disease. These aforementioned projects had contributed in 13 presentations at national and international conferences, as well as 13 peer-reviewed articles. These publications had been cited 65 times at the time of filing this case. In addition to researching and publishing his work, this client had served as a manuscript reviewer for 12 internationally-circulated journals. One recommender explained: “Epilepsy is the fourth most common neurological disorder in the world, afflicting 7 people out of every 1000, with 40 million cases worldwide. In the United States, there are currently at least 2.3 million people currently living with and seeking treatment for epilepsy. Yearly, 200,000 new cases are reported, and an estimated 25,000 to 50,000 patients die of seizures or related causes. The attendant economic impact of this condition is estimated at around $12.5 billion each year. Considering these statistics, there could not be a clearer need or more appropriate time for the acquisition and application of [Client’s] research.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Pharmaceutical Science, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, this EB-1A (Alien of Extraordinary Ability) petition received approval only 50 days after filing the case.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%